We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock
DMTK

Delisted

DMTK was delisted on the 26th of June, 2024.

Back to rankings

9 hedge funds and large institutions have $44.7M invested in DermTech, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more capital invested

Capital invested by funds: $21.5M → $44.7M (+$23.2M)

25% less funds holding

Funds holding: 12 → 9 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
-3
Holders Change %
-25%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.84M
2
VF
Virtu Financial
New York
+$113K
3
CC
Centiva Capital
New York
+$107K
4
Millennium Management
Millennium Management
New York
+$93.7K
5
UBS Group
UBS Group
Switzerland
+$4.04K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.39M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$651K
3
CAC
Cowen and Company
New York
-$515K
4
KC
Kepos Capital
New York
-$434K
5
BFM
Boothbay Fund Management
New York
-$84K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$28.4M – – –
FCM
2
Farallon Capital Management
California
$7.63M – – –
Victory Capital Management
3
Victory Capital Management
Texas
$3.81M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.6M +$1.84M +209,393 New
CAC
5
Cowen and Company
New York
$1.79M -$515K -58,746 -29%
VF
6
Virtu Financial
New York
$160K +$113K +12,916 New
CC
7
Centiva Capital
New York
$151K +$107K +12,187 New
Millennium Management
8
Millennium Management
New York
$132K +$93.7K +10,681 New
UBS Group
9
UBS Group
Switzerland
$6K +$4.04K +461 New
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
– -$1.39M -247,500 Closed
PAMP
11
Polar Asset Management Partners
Ontario, Canada
– -$651K -116,282 Closed
KC
12
Kepos Capital
New York
– -$434K -77,525 Closed
BFM
13
Boothbay Fund Management
New York
– -$84K -15,000 Closed
BCM
14
BlueCrest Capital Management
Jersey
– -$79K -14,146 Closed
KA
15
Kovack Advisors
Florida
– -$73K -13,000 Closed
LIM
16
Longfellow Investment Management
Massachusetts
– -$6K -1,002 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$1K -200 Closed

DMTK Hedge Fund Activity: Q4 2019 in Review

9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2019, worth a combined $44.7M — up 108% from $21.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DMTK and 5 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.84M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $1.39M sold.

  • 9 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2019, down from 12 in Q3 2019.
  • Funds reported $44.7M of DermTech, Inc. Common Stock stock for Q4 2019, up 108% quarter-over-quarter.
  • 5 funds opened new DermTech, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of -3 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q4 2019 was Vanguard Group, an estimated $1.84M added.
  • The largest DermTech, Inc. Common Stock seller in Q4 2019 was D.E. Shaw & Co, an estimated $1.39M sold.

Based on aggregated 13F filings for Q4 2019.